TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Aarti Drugs Limited ( (IN:AARTIDRUGS) ) has shared an announcement.
Aarti Drugs Limited announced that the Bombay High Court has set aside an order previously issued by the CGST & C.Ex. Authority, which had demanded a significant IGST payment along with interest and penalties. This favorable court decision means there will be no financial or operational impact on the company, ensuring stability in its ongoing activities and maintaining its market position.
More about Aarti Drugs Limited
Aarti Drugs Limited is a company operating in the pharmaceutical industry, focusing on the production of active pharmaceutical ingredients (APIs), intermediates, and specialty chemicals. The company caters to both domestic and international markets, providing essential components for various therapeutic segments.
Average Trading Volume: 32,649
Technical Sentiment Signal: Buy
Current Market Cap: 44.85B INR
For an in-depth examination of AARTIDRUGS stock, go to TipRanks’ Overview page.